👍👍👍

@Mrzorro
The Worst-Performing S&P 500 Stocks in January The $S&P 500(.SPX)$ kicked off the new year with a rally, advancing 5.5% in January. That's welcome news for investors who are still recovering from the S&P 500's 19% loss in 2022. But not every stock is enjoying the new year. Some sectors that outperformed the S&P 500 last year, like energy, lost their steam this month as investors anticipated a slowdown in the Fed's campaign to raise interest rates and grew more bullish about high-growth names such as $Tesla Motors(TSLA)$ and $Western Digital(WDC)$. Solar panel manufacturer $Enphase Energy(ENPH.US)$ was among the S&P 500's five worst performers in January. The list, which can be seen below, is based on midday Tuesday trading and will be updated at the close. 5. Archer Daniels Midland Shares of $Archer Daniels Midland(ADM.US)$ are down 11.4% in January. One of the biggest agricultural companies, Archer Daniels Midland posted a better-than-expected fourth-quarter profit this month. Management, however, predicted its Ag Services segment is likely to see a pulldown in the business in the current quarter compared to last year's strong quarter. 4. Baxter International Shares of $Baxter International Inc(BAX.US)$, another healthcare company, are down 11% in January, their worst month since June last year. Earlier this month, the company's chief operating officer resigned. Separately, Baxter announced a plan to split off its largest unit, kidney care. 3. Pfizer $Pfizer(PFE)$ shares are down 15% in January, the third worst performer in the S&P 500. The drug maker on Tuesday laid out a financial forecast for the 2023 fiscal year well below Wall Street consensus figures. The company expects fewer people to receive Covid-19 vaccines in 2023. The company's stock was down 10% in 2022. 2. Enphase Energy The fortunes of Enphase Energy changed in January. The stock, which was up 45% in 2022, is down about 16% in January, making it the S&P 500’s No. 2 worst performer for the month. While energy was the top-performing sector in 2022—the $Energy Select Sector SPDR Fund(XLE.US)$ gained 64%—energy names have slowed generally. That fund is up 2% this year. 1. Northrop Grumman $Northrop Grumman(NOC.US)$ came in as the index’s worst performer for January, sliding 18% in January. That marks the stock’s worst month since early 2009. The defense system maker for the U.S. Navy delivered better-than-expected profits for the fourth quarter last week. Shares of the company climbed more than 40% in 2022. @TigerStars @Daily_Discussion
The Worst-Performing S&P 500 Stocks in January The $S&P 500(.SPX)$ kicked off the new year with a rally, advancing 5.5% in January. That's welcome news for investors who are still recovering from the S&P 500's 19% loss in 2022. But not every stock is enjoying the new year. Some sectors that outperformed the S&P 500 last year, like energy, lost their steam this month as investors anticipated a slowdown in the Fed's campaign to raise interest rates and grew more bullish about high-growth names such as $Tesla Motors(TSLA)$ and $Western Digital(WDC)$. Solar panel manufacturer $Enphase Energy(ENPH.US)$ was among the S&P 500's five worst performers in January. The list, which can be seen below, is based on midday Tuesday trading and will be updated at the close. 5. Archer Daniels Midland Shares of $Archer Daniels Midland(ADM.US)$ are down 11.4% in January. One of the biggest agricultural companies, Archer Daniels Midland posted a better-than-expected fourth-quarter profit this month. Management, however, predicted its Ag Services segment is likely to see a pulldown in the business in the current quarter compared to last year's strong quarter. 4. Baxter International Shares of $Baxter International Inc(BAX.US)$, another healthcare company, are down 11% in January, their worst month since June last year. Earlier this month, the company's chief operating officer resigned. Separately, Baxter announced a plan to split off its largest unit, kidney care. 3. Pfizer $Pfizer(PFE)$ shares are down 15% in January, the third worst performer in the S&P 500. The drug maker on Tuesday laid out a financial forecast for the 2023 fiscal year well below Wall Street consensus figures. The company expects fewer people to receive Covid-19 vaccines in 2023. The company's stock was down 10% in 2022. 2. Enphase Energy The fortunes of Enphase Energy changed in January. The stock, which was up 45% in 2022, is down about 16% in January, making it the S&P 500’s No. 2 worst performer for the month. While energy was the top-performing sector in 2022—the $Energy Select Sector SPDR Fund(XLE.US)$ gained 64%—energy names have slowed generally. That fund is up 2% this year. 1. Northrop Grumman $Northrop Grumman(NOC.US)$ came in as the index’s worst performer for January, sliding 18% in January. That marks the stock’s worst month since early 2009. The defense system maker for the U.S. Navy delivered better-than-expected profits for the fourth quarter last week. Shares of the company climbed more than 40% in 2022. @TigerStars @Daily_Discussion

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet